Professor of Medical Pathology, University of Minnesota, Distinguished Professor of Hunan Cancer Hospital
Department of Experimental Medicine and Pathology, University of Minnesota School of Medicine, Senior Researcher at Masonic Cancer Research Center, Visiting Professor of Central South University and Distinguished Professor of Hunan Cancer Hospital and Xiangya Medical College Affiliated Cancer Hospital, Hunan Province "Hundred Talents Program" scholar. Dr. Yang Jianbo has long been engaged in the research on the signal transduction mechanism of the occurrence and development of malignant tumors, and has made in-depth explorations in the individualized molecular targeted therapy of malignant tumors (melanoma, breast cancer, lung cancer, ovarian cancer, etc.), and cellular immunotherapy. In terms of basic research on malignant tumors, Dr. Yang Jianbo is responsible for the implementation of a number of scientific research projects funded by NIH and the National Natural Science Foundation of the United States, and has published dozens of SCI monographs in international tumor research journals. Through the research on the function and mechanism of tumor-specific antigens, Dr. Yang Jianbo presided over the research and development of "the application of new multifunctional targeted fusion protein antibodies in the individualized treatment of malignant tumors" and "the application of new magnetic beading antibodies in the detection and Projects such as the application of separating tumor cells from peripheral blood are undergoing clinical transformation.